Results 1 to 10 of about 1,846,553 (245)

Cross-reactive broadly neutralizing antibodies: timing is everything [PDF]

Frontiers in Immunology, 2012
The recent surge of research into new broadly neutralizing antibodies in HIV-1 infection has recharged the field of HIV-1 vaccinology. In this review we discuss the currently known broadly neutralizing antibodies and focus on factors that may shape these
Zelda eEuler, Hanneke eSchuitemaker, Hanneke eSchuitemaker   +2 more
doaj   +2 more sources

Lack of protection following passive transfer of polyclonal highly functional low-dose non-neutralizing antibodies. [PDF]

PLoS ONE, 2014
Recent immune correlates analysis from the RV144 vaccine trial has renewed interest in the role of non-neutralizing antibodies in mediating protection from infection.
Anne-Sophie Dugast, Ying Chan, Michelle Hoffner, Anna Licht, Joseph Nkolola, Hualin Li, Hendrik Streeck, Todd J Suscovich, Musie Ghebremichael, Margaret E Ackerman, Dan H Barouch, Galit Alter   +11 more
doaj   +6 more sources

In vivo emergence of HIV-1 highly sensitive to neutralizing antibodies. [PDF]

PLoS ONE, 2011
BackgroundThe rapid and continual viral escape from neutralizing antibodies is well documented in HIV-1 infection. Here we report in vivo emergence of viruses with heightened sensitivity to neutralizing antibodies, sometimes paralleling the development ...
Marlén M I Aasa-Chapman, Kelly M Cheney, Stéphane Hué, Anna Forsman, Stephen O'Farrell, Pierre Pellegrino, Ian Williams, Áine McKnight   +7 more
doaj   +8 more sources

SARS-CoV-2 Neutralizing Antibodies 2.0 [PDF]

Viruses
As the SARS-CoV-2 mutates, especially into those variants causing immune escape, COVID-19 continues to wreak havoc [...]
Youchun Wang
doaj   +2 more sources

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

eLife, 2020
Neutralizing antibodies elicited by prior infection or vaccination are likely to be key for future protection of individuals and populations against SARS-CoV-2.
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio CC Lorenzi, Frauke Muecksch, Magdalena Rutkowska, Hans-Heinrich Hoffmann, Eleftherios Michailidis, Christian Gaebler, Marianna Agudelo, Alice Cho, Zijun Wang, Anna Gazumyan, Melissa Cipolla, Larry Luchsinger, Christopher D Hillyer, Marina Caskey, Davide F Robbiani, Charles M Rice, Michel C Nussenzweig, Theodora Hatziioannou, Paul D Bieniasz   +23 more
doaj   +2 more sources

Molecular convergence of neutralizing antibodies in human revealed by repeated rabies vaccination [PDF]

npj Vaccines
Rabies vaccines require repeated immunization to robustly elicit neutralizing antibodies that prevent fatal diseases. Here, we analyzed rabies glycoprotein antibody repertoires at both polyclonal and monoclonal levels following repeated vaccination ...
Mizuki Fujisawa, Taishi Onodera, Daisuke Kuroda, Chidchamai Kewcharoenwong, Michihito Sasaki, Yukari Itakura, Kohei Yumoto, Arnone Nithichanon, Naoto Ito, Shinji Takeoka, Tadaki Suzuki, Hirofumi Sawa, Ganjana Lertmemongkolchai, Yoshimasa Takahashi   +13 more
doaj   +2 more sources

The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein [PDF]

mBio, 2013
Following natural dengue virus (DENV) infection, humans produce some antibodies that recognize only the serotype of infection (type specific) and others that cross-react with all four serotypes (cross-reactive).
Scott A. Smith, A. Ruklanthi de Alwis, Nurgun Kose, Eva Harris, Kristie D. Ibarra, Kristen M. Kahle, Jennifer M. Pfaff, Xiaoxiao Xiang, Benjamin J. Doranz, Aravinda M. de Silva, S. Kyle Austin, Soila Sukupolvi-Petty, Michael S. Diamond, James E. Crowe   +13 more
doaj   +4 more sources

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Nature, 2020
Jinfang Yu, Jincun Zhao, Jiwan Ge
exaly   +2 more sources

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Nature, 2020
David D Ho, Manoj S Nair, Yaoxing Huang
exaly   +2 more sources

Age-specific kinetics of neutralizing antibodies and infection enhancement among ≤1 year-old Indian infants [PDF]

Frontiers in Cellular and Infection Microbiology
BackgroundInfants born to dengue-immune mothers acquire maternal antibodies to dengue. Maternal antibodies decline over time, making infants susceptible to primary dengue infections. Another important concern is the role of maternal antibodies in causing
Shweta Chelluboina, Akhilesh Chandra Mishra, Vidya Avinash Arankalle, Shubham Shrivastava   +3 more
doaj   +2 more sources